Single and Multiple Doses of an Oral Formulation of L-Homoarginine in Healthy Human Subjects

NCT02675660 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Universitätsklinikum Hamburg-Eppendorf